{
    "organizations": [],
    "uuid": "9d41813511811fd617a4a26542a84457fe3b30eb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-karyopharm-therapeutics-announces/brief-karyopharm-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASC09YSZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Karyopharm Therapeutics Inc:\n* KARYOPHARM THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* COMMENCEMENT OF A REGISTERED UNDERWRITTEN PUBLIC OFFERING OF $125 MILLION IN SHARES OF ITS COMMON STOCK\n* INTENDS TO USE NET PROCEEDS OF OFFERING TO SUPPORT CONTINUED CLINICAL DEVELOPMENT OF SELINEXOR\n* TO USE PROCEEDS OF OFFERING TO CONTINUE ESTABLISHING COMMERCIAL INFRASTRUCTURE FOR POTENTIAL LAUNCH OF SELINEXOR IN U.S. Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T00:42:00.000+03:00",
    "crawled": "2018-05-02T01:01:12.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "karyopharm",
        "therapeutic",
        "inc",
        "karyopharm",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "commencement",
        "registered",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "intends",
        "use",
        "net",
        "proceeds",
        "offering",
        "support",
        "continued",
        "clinical",
        "development",
        "selinexor",
        "use",
        "proceeds",
        "offering",
        "continue",
        "establishing",
        "commercial",
        "infrastructure",
        "potential",
        "launch",
        "selinexor",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}